 Pseudomonas Infections
"Pseudomonas Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infections with bacteria of the genus PSEUDOMONAS.
| Descriptor ID |
D011552
|
| MeSH Number(s) |
C01.252.400.739
|
| Concept/Terms |
Pseudomonas Infections- Pseudomonas Infections
- Infections, Pseudomonas
- Infection, Pseudomonas
- Pseudomonas Infection
|
Below are MeSH descriptors whose meaning is more general than "Pseudomonas Infections".
Below are MeSH descriptors whose meaning is more specific than "Pseudomonas Infections".
This graph shows the total number of publications written about "Pseudomonas Infections" by people in this website by year, and whether "Pseudomonas Infections" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 | | 2015 | 1 | 0 | 1 | | 2021 | 1 | 0 | 1 | | 2023 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Pseudomonas Infections" by people in Profiles.
-
Kanwar N, Harrison CJ, Pence MA, Qin X, Selvarangan R. Comparative in vitro antipseudomonal activity of ceftolozane/tazobactam against Pseudomonas aeruginosa isolates from children with cystic fibrosis. Diagn Microbiol Infect Dis. 2023 Apr; 105(4):115904.
-
Nichols DP, Singh PK, Baines A, Caverly LJ, Chmiel JF, GIbson RL, Lascano J, Morgan SJ, Retsch-Bogart G, Saiman L, Sadeghi H, Billings JL, Heltshe SL, Kirby S, Kong A, Nick JA, Mayer-Hamblett N. Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial. Thorax. 2022 06; 77(6):581-588.
-
Li R, Fang L, Pu Q, Bu H, Zhu P, Chen Z, Yu M, Li X, Weiland T, Bansal A, Ye SQ, Wei Y, Jiang J, Wu M. MEG3-4 is a miRNA decoy that regulates IL-1? abundance to initiate and then limit inflammation to prevent sepsis during lung infection. Sci Signal. 2018 06 26; 11(536).
-
Ehsan Z, Clancy JP. Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin. Future Microbiol. 2015; 10(12):1901-12.
-
Ehsan Z, Wetzel JD, Clancy JP. Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients. Expert Opin Investig Drugs. 2014 May; 23(5):743-9.
-
Warady BA, Campoy SF, Gross SP, Sedman AB, Lum GM. Peritonitis with continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis. J Pediatr. 1984 Nov; 105(5):726-30.
-
Leeder JS, Spino M, Isles AF, Tesoro AM, Gold R, MacLeod SM. Ceftazidime disposition in acute and stable cystic fibrosis. Clin Pharmacol Ther. 1984 Sep; 36(3):355-62.
-
L?nyi B, Lantos J. Antigenic changes in Pseudomonas aeruginosa in vivo and after lysogenization in vitro. Acta Microbiol Acad Sci Hung. 1976; 23(4):337-51.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|